v3.26.1
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
May 21, 2026
Dec. 07, 2025
Sep. 11, 2025
Jun. 03, 2025
Apr. 18, 2024
Apr. 24, 2023
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2021
Sep. 10, 2021
Dec. 31, 2016
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Common stock, shares authorized             200,000,000       200,000,000   200,000,000      
Preferred stock, shares authorized             10,000,000       10,000,000   10,000,000      
Preferred stock, par value             $ 0.0001       $ 0.0001   $ 0.0001      
PreFunded warrant effect description   (i) the aggregate number of shares of common stock beneficially owned by such holder (together with its affiliates) to exceed 4.99% of the total number of shares of common stock outstanding immediately after giving effect to the exercise; or (ii) the combined voting power of the Company’s securities beneficially owned by such holder (together with its affiliates) to exceed 4.99% of the combined voting power of all of the Company’s securities immediately outstanding after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Pre-Funded Warrant, which percentage may be changed at the holder’s election to a higher or lower percentage not in excess of 19.99% upon at least 61 days’ notice to the Company.                            
Number of shares issued, value                              
Number of shares issued upon exercise                     27,480          
Proceeds from stock options exercised                     $ 44,692 $ 5,824        
Options granted to purchase common stock                     1,665,750          
Stock based compensation             $ 910,640   $ 389,702   $ 1,418,705 824,404        
Unrecognized stock-based compensation expense             $ 13,333,458       $ 13,333,458          
Weighted-average vesting period                     3 years 5 months 26 days          
Intrinsic value option vested                     $ 44,727,130          
Non-Employees [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Options granted to purchase common stock                     87,500          
Options term                     10 years          
Exercise price per share                     $ 8.78          
Non-Employees [Member] | Minimum [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Vesting period                     12 months          
Non-Employees [Member] | Maximum [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Vesting period                     48 months          
Management of the Company [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Options granted to purchase common stock                     1,000,000          
Employees [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Options granted to purchase common stock                     578,250          
Options term                     10 years          
Vesting period                     48 months          
Employees [Member] | Minimum [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Exercise price per share, lower range limit                     $ 8.07          
Employees [Member] | Maximum [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Exercise price per share, upper range limit                     $ 9.30          
Restricted Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Stock-based compensation expense                       $ 167,408        
Unrecognized stock-based compensation expense                         $ 0      
2016 Plan [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued                           1,761,120   417,120
2021 Plan [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued             3,391,795       3,391,795       900,000  
Amended and Restated 2021 Omnibus Equity Incentive Plan [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Common stock number of shares to be issued           1,034,561                    
Share price percentage           5.00%                    
Amended and Restated 2022 Omnibus Equity Incentive Plan [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Common stock number of shares to be issued         3,000,000                      
Total number of shares reserve         4,934,561                      
Underwritten Offering [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Shares price per share   $ 5.10                            
Number of shares issued   19,117,646                            
Underwritten Offering [Member] | PreFunded Warrant [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Shares price per share   $ 5.09                            
Exercise price   $ 0.01                            
Warrant issued   490,196                            
Common Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued             16,778,524                  
Number of shares issued                   164,315            
Number of shares issued, value                   $ 16            
Number of shares issued upon exercise             6,000 21,480   4,500            
Common Stock [Member] | Nexcella 2022 Equity Incentive Plan [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued                     275,759          
Warrant [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Class of Warrant or Right, Outstanding     2,936,709                          
Intrinsic value of warrants vested and outstanding             $ 48,062,072       $ 48,062,072          
Citizens ATM Agreement [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Proceeds from issuance initial public offering       $ 100,000,000                        
Shares sold                     1,510,000          
Number of shares sold, value                     $ 13,943,659          
Citizens ATM Agreement [Member] | Common Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Shares sold                     3,207,504          
Number of shares sold, value                     $ 18,353,089          
Securities Purchase Agreements [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Shares price per share     $ 2.37                          
Proceeds from Issuance of Private Placement     $ 9,300,000                          
Warrants term     10 years                          
Exercise price     $ 2.00                          
Securities Purchase Agreements [Member] | Common Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Stock Issued During Period, Shares, Other     3,915,604                          
Securities Purchase Agreements [Member] | Warrant [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Class of Warrant or Right, Outstanding     2,936,709                          
2026 Underwriting Agreement [Member] | Common Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Shares sold 16,778,524                              
Number of shares sold, value $ 140,700,000                              
Shares price per share $ 8.94                              
Marketing Service Agreement [Member] | July 25, 2023 [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued                     18,346          
Number of shares issued, value                     $ 135,000          
Marketing Services Agreement [Member] | Common Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued                     28,707          
Number of shares issued upon exercise                     27,480          
Proceeds from stock options exercised                     $ 44,692          
Number of exercise warrants, shares                     221,519          
Number of exercise warrants value                     $ 441,202          
Marketing Services Agreement [Member] | Common Stock Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued                     64,338